HS-140

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHS-140
Drug Alias NamePIM-2 kinase inhibitor (North Carolina Central University/Duke University)HS-140 (North Carolina Central University/Duke University)HS-140
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase pim-2 inhibitors
TargetsSerine/threonine-protein kinase pim-2
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNorth Carolina Central University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorth Carolina Central UniversityDuke University
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A